tiprankstipranks
Trending News
More News >
Cipher Pharmaceuticals (TSE:CPH)
TSX:CPH
Canadian Market

Cipher Pharmaceuticals (CPH) Ratios

Compare
87 Followers

Cipher Pharmaceuticals Ratios

TSE:CPH's free cash flow for Q3 2025 was $―. For the 2025 fiscal year, TSE:CPH's free cash flow was decreased by $ and operating cash flow was $―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.72 9.19 4.07 2.39 2.03
Quick Ratio
1.41 8.62 3.84 2.25 1.94
Cash Ratio
0.64 7.58 3.08 1.67 0.92
Solvency Ratio
0.45 3.92 2.85 0.66 0.49
Operating Cash Flow Ratio
1.19 3.05 1.13 1.12 1.18
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ -12.41M$ 42.76M$ 28.46M$ 16.57M$ 8.49M
Leverage Ratios
Debt-to-Assets Ratio
0.17 <0.01 <0.01 <0.01 0.04
Debt-to-Equity Ratio
0.23 <0.01 <0.01 0.01 0.06
Debt-to-Capital Ratio
0.19 <0.01 <0.01 0.01 0.05
Long-Term Debt-to-Capital Ratio
0.19 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.39 1.07 1.15 1.33 1.36
Debt Service Coverage Ratio
0.00 0.00 58.42 112.59 34.83
Interest Coverage Ratio
0.00 0.00 23.89 128.49 37.76
Debt to Market Cap
0.09 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.98 0.01 <0.01 0.02 0.08
Net Debt to EBITDA
0.84 -3.42 -2.38 -1.47 -0.54
Profitability Margins
Gross Profit Margin
73.79%80.77%80.69%83.21%85.85%
EBIT Margin
20.32%48.68%53.45%59.51%56.30%
EBITDA Margin
35.16%54.48%57.80%62.25%62.02%
Operating Profit Margin
24.36%54.48%53.62%53.87%56.44%
Pretax Profit Margin
12.11%59.92%55.52%50.40%30.25%
Net Profit Margin
25.52%96.32%128.83%35.36%21.05%
Continuous Operations Profit Margin
25.52%96.32%128.83%35.36%20.30%
Net Income Per EBT
210.69%160.74%232.04%70.15%69.60%
EBT Per EBIT
49.72%109.99%103.55%93.55%53.59%
Return on Assets (ROA)
7.97%23.69%36.10%15.02%10.27%
Return on Equity (ROE)
11.68%25.31%41.57%19.94%13.94%
Return on Capital Employed (ROCE)
8.61%14.27%17.21%30.04%35.50%
Return on Invested Capital (ROIC)
18.11%22.91%39.87%21.04%23.72%
Return on Tangible Assets
20.36%29.73%48.15%24.02%18.65%
Earnings Yield
4.47%19.15%8.75%20.84%23.06%
Efficiency Ratios
Receivables Turnover
4.01 4.16 3.04 3.30 2.34
Payables Turnover
2.57 0.88 0.97 0.66 1.86
Inventory Turnover
2.24 1.36 1.86 2.23 3.43
Fixed Asset Turnover
91.17 52.64 42.98 43.80 11.33
Asset Turnover
0.31 0.25 0.28 0.42 0.49
Working Capital Turnover Ratio
2.69 0.59 0.90 1.61 3.99
Cash Conversion Cycle
112.38 -60.88 -58.67 -276.15 65.84
Days of Sales Outstanding
91.02 87.76 120.08 110.75 155.75
Days of Inventory Outstanding
163.13 267.49 196.76 163.48 106.50
Days of Payables Outstanding
141.78 416.13 375.51 550.37 196.41
Operating Cycle
254.15 355.25 316.85 274.23 262.25
Cash Flow Ratios
Operating Cash Flow Per Share
0.82 0.63 0.10 0.52 0.43
Free Cash Flow Per Share
0.82 0.63 0.10 0.52 0.40
CapEx Per Share
<0.01 <0.01 <0.01 0.00 0.03
Free Cash Flow to Operating Cash Flow
1.00 1.00 0.99 1.00 0.93
Dividend Paid and CapEx Coverage Ratio
728.52 111.10 130.56 0.00 15.38
Capital Expenditure Coverage Ratio
728.52 111.10 130.56 0.00 15.38
Operating Cash Flow Coverage Ratio
0.83 45.32 24.71 26.77 6.32
Operating Cash Flow to Sales Ratio
0.44 0.76 0.51 0.63 0.54
Free Cash Flow Yield
7.92%15.01%3.45%37.11%55.42%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
22.41 5.22 11.43 4.80 4.34
Price-to-Sales (P/S) Ratio
5.61 5.03 14.73 1.70 0.91
Price-to-Book (P/B) Ratio
2.49 1.32 4.75 0.96 0.60
Price-to-Free Cash Flow (P/FCF) Ratio
12.65 6.66 29.01 2.69 1.80
Price-to-Operating Cash Flow Ratio
12.88 6.65 28.79 2.69 1.69
Price-to-Earnings Growth (PEG) Ratio
0.73 0.02 -0.83 0.07 0.10
Price-to-Fair Value
2.49 1.32 4.75 0.96 0.60
Enterprise Value Multiple
16.79 5.81 23.10 1.26 0.93
Enterprise Value
280.61M 66.94M 276.07M 17.19M 12.43M
EV to EBITDA
16.77 5.81 23.10 1.26 0.93
EV to Sales
5.90 3.16 13.35 0.78 0.58
EV to Free Cash Flow
13.30 4.19 26.31 1.24 1.14
EV to Operating Cash Flow
13.28 4.18 26.11 1.24 1.06
Tangible Book Value Per Share
0.65 2.47 0.42 0.73 0.47
Shareholders’ Equity Per Share
4.23 3.16 0.60 1.46 1.21
Tax and Other Ratios
Effective Tax Rate
-1.11 -0.61 -1.32 0.30 0.33
Revenue Per Share
1.84 0.83 0.19 0.82 0.80
Net Income Per Share
0.47 0.80 0.25 0.29 0.17
Tax Burden
2.11 1.61 2.32 0.70 0.70
Interest Burden
0.60 1.23 1.04 0.85 0.54
Research & Development to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
0.34 0.25 0.21 0.00 0.00
Stock-Based Compensation to Revenue
0.03 0.06 0.02 <0.01 <0.01
Income Quality
1.74 0.78 0.40 1.78 2.67
Currency in USD